Condition: Cerebral Palsy Children · Motor Disabilities · Developmental Disability · Sponsor: Oregon Health and Science University
The goal of this clinical trial is to learn if a therapist training program can help providers in Part C Early Childhood Settings use powered mobility (PM) with young children who have cerebral palsy (Gross Motor Function Classification System Levels IV-V). The study will also look at whether this training is practical and useful for therapists, families, and children. The main questions it aims to answer are: 1. Can therapists successfully use the training to provide powered mobility interventions in home and early childhood settings? 2. Do families and children find the intervention acceptable and helpful? 3. What benefits do children show in mobility, participation, and engagement after using powered mobility? In this study, therapists and families will: 1. Take part in a training program about how to use powered mobility with young children 2. Use powered mobility devices (Permobil Explorer Mini) with children during everyday routines 3. Complete surveys, interviews, and observations about their experiences
This description comes directly from the study's public registry record.
Bethany M Sloane, PT, DPT, PhD · 503-494-3232 · sloaneb@ohsu.edu
Always discuss trial participation with your own doctor first.
| Northwest Regional Education Service District | Hillsboro, Oregon, United States | Recruiting |
| Multnomah Early Childhood Program | Portland, Oregon, United States | Recruiting |
| Oregon Health & Science University | Portland, Oregon, United States | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07220590